WHO ICTRP trial

Does real-time patient analysis of continuous glucose monitor data improve…

ACTRN12606000049572 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12606000049572
Public title Does real-time patient analysis of continuous glucose monitor data improve glycaemic control in patients with Type 1 diabetes on insulin pump therapy?
Scientific title Does real-time patient analysis of continuous glucose monitor data improve glycaemic control in patients with Type 1 diabetes on insulin pump therapy? A randomised controlled trial of the MiniMed Paradigm Real Time Insulin Pump and Continuous Glucose Monitoring System.
Primary sponsor Each site is individually sponsoring the trial at that site. Royal Children's Hospital, Parkville, Vic 3052
Secondary sponsors Royal Melbourne Hospital Vic;St Vincent's Hospital Melbourne Vic;Princess Margaret Hospital Perth WA;The Children's Hospital at Westmead, NSW
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Countries Australia
Conditions Type 1 Diabetes Mellitus; Type 1 Diabetes Mellitus;Metabolic and Endocrine - Diabetes
Interventions In recent years, continuous glucose monitoring systems have been developed. Most currently available continuous glucose monitors measure glucose with minimal invasiveness through continuous measurement of interstitial fluid. Results from…
Registration date Jan 2, 2006
Target size 40
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations